Presentation of the Centre
Institut Universitaire du Cancer Toulouse – Oncopole combines a centenary affiliated cancer centers in France, Oncopole Claudius Regaud, and Toulouse University Hospital oncology teams. It is strategically and physically linked to CRCT (Toulouse Cancer Research Center).
This Comprehensive Cancer Center treats cancer patients, develops basic, transfer and clinical research and provides teaching. Opened 10 years ago in 2014, IUCT-Oncopole is involved in 11 113 new cases of cancer each year management. 2 175 staff-members including 191 physicians and 147 researchers are devoted to therapeutic innovation.
The proximity and the pooling of platforms foster the care/research continuum
Main research activities
The CRCT (INSERM, CNRS and University) integrates research programs in 4 different fields: Cell Signaling & DNA Damage Response, RNA & Cancer, Microenvironment & Metabolism, Onco-Immunology. Its purpose is to solve problems and making discoveries through basic science that can lead to the development of anticancer agents and treatments.
Core Facilities
The innovative techniques for diagnosis and treatment at the service of patients for a global management:
- Medical oncology : 105 beds & places, oncogenetic service, MDT meetings, supportive care (therapeutic educational program, palliative care…).
- Clinical Trials: INCa-certified early phase centre by the French Cancer Institute, certified ISO 9001:2015, conducting phase I trials (part of the leading 3 national centers).
- Surgery: 65 beds & places,7 operating rooms, 50% of outpatient care for senology ; telerobotic, local cryotherapy (urology), per operative radiotherapy...
- Hematology and Internal Medicine: 100 beds & places, 150 clinical trials in progress.
- Nuclear medicine & Imaging: 18 beds & places, PET Scan, MRI, gamma cameras, 3D imaging.
- Radiotherapy: 7 accelerators (including tomotherapy), innovative techniques.
- Resuscitation unit: 12 beds
- Anatomopathology: telepathology, liquid and solid tumors, 1 000 exams/week, 2 special rooms for analyzing surgery samples quickly.
- Pharmacy: 125 000 chemotherapies/year, radiopharmacy, certified ISO 9001:2015
Education
Major changes in the practice of oncology must be taken into account and anticipated in training and teaching. This center of convergence for all disciplines represents an ideal forum for initial and continued training across the entire oncology fields.